Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys

被引：314

作者：

Barouch, Dan H. ^{[1
,2
,3
]}

O'Brien, Kara L. ^{[1
]}

Simmons, Nathaniel L. ^{[1
]}

King, Sharon L. ^{[1
]}

Abbink, Peter ^{[1
]}

Maxfield, Lori F. ^{[1
]}

Sun, Ying-Hua ^{[1
]}

La Porte, Annalena ^{[1
]}

Riggs, Ambryice M. ^{[1
]}

Lynch, Diana M. ^{[1
]}

Clark, Sarah L. ^{[1
]}

Backus, Katherine ^{[1
]}

Perry, James R. ^{[1
]}

Seaman, Michael S. ^{[1
]}

Carville, Angela ^{[4
]}

Mansfield, Keith G. ^{[4
]}

Szinger, James J. ^{[5
]}

Fischer, Will ^{[5
]}

Muldoon, Mark ^{[6
,7
]}

Korber, Bette ^{[5
,7
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA

[2] Massachusetts Gen Hosp, Ragon Inst, MIT, Boston, MA 02114 USA

[3] Harvard Univ, Boston, MA 02115 USA

[4] New England Reg Primate Res Ctr, Southborough, MA 01772 USA

[5] Los Alamos Natl Lab, Los Alamos, NM USA

[6] Univ Manchester, Sch Math, Manchester, Lancs, England

[7] Santa Fe Inst, Santa Fe, NM 87501 USA

来源：

NATURE MEDICINE | 2010年 / 16卷 / 03期

基金：

美国国家卫生研究院;

关键词：

HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNOGENICITY; REPLICATION; VARIANTS; VECTORS; STEP;

D O I：

10.1038/nm.2089

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The worldwide diversity of HIV-1 presents an unprecedented challenge for vaccine development(1,2). Antigens derived from natural HIV-1 sequences have elicited only a limited breadth of cellular immune responses in nonhuman primate studies and clinical trials to date. Polyvalent 'mosaic' antigens, in contrast, are designed to optimize cellular immunologic coverage of global HIV-1 sequence diversity(3). Here we show that mosaic HIV-1 Gag, Pol and Env antigens expressed by recombinant, replication-incompetent adenovirus serotype 26 vectors markedly augmented both the breadth and depth without compromising the magnitude of antigen-specific T lymphocyte responses as compared with consensus or natural sequence HIV-1 antigens in rhesus monkeys. Polyvalent mosaic antigens therefore represent a promising strategy to expand cellular immunologic vaccine coverage for genetically diverse pathogens such as HIV-1.

引用

页码：319 / U116

页数：6

共 20 条

[1] Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Abbink, Peter
Lemckert, Angelique A. C.
Ewald, Bonnie A.
Lynch, Diana M.
Denholtz, Matthew
Smits, Shirley
Holterman, Lennart
Damen, Irma
Vogels, Ronald
Thorner, Anna R.
O'Brien, Kara L.
Carville, Angela
Mansfield, Keith G.
Goudsmit, Jaap
Havenga, Menzo J. E.
Barouch, Dan H.
[J]. JOURNAL OF VIROLOGY, 2007, 81 (09) : 4654 - 4663
[2] Challenges in the development of an HIV-1 vaccine
Barouch, Dan H.
[J]. NATURE, 2008, 455 (7213) : 613 - 619
[3] Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants
Barouch, DH
Powers, J
Truitt, DM
Kishko, MG
Arthur, JC
Peyerl, FW
Kuroda, MJ
Gorgone, DA
Lifton, MA
Lord, CI
Hirsch, VM
Montefiori, DC
Carville, A
Mansfield, KG
Kunstman, KJ
Wolinsky, SM
Letvin, NL
[J]. NATURE IMMUNOLOGY, 2005, 6 (03) : 247 - 252
[4] Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species
Barry, Ashley P.
Silvestri, Guido
Safrit, Jeffrey T.
Sumpter, Beth
Kozyr, Natalia
McClure, Harold M.
Staprans, Silvija I.
Feinberg, Mark B.
[J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (12) : 8002 - 8012
[5] Bates D., 2009, Mixed-Effects Models in S and S-PLUS
[6] Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Buchbinder, Susan P.
Mehrotra, Devon V.
Duerr, Ann
Fitzgerald, Daniel W.
Mogg, Robin
Li, David
Gilbert, Peter B.
Lama, Javier R.
Marmor, Michael
del Rio, Carlos
McElrath, M. Juliana
Casimiro, Danilo R.
Gottesdiener, Keith M.
Chodakewitz, Jeffrey A.
Corey, Lawrence
Robertson, Michael N.
[J]. LANCET, 2008, 372 (9653) : 1881 - 1893
[7] Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Fischer, Will
Perkins, Simon
Theiler, James
Bhattacharya, Tanmoy
Yusim, Karina
Funkhouser, Robert
Kuiken, Carla
Haynes, Barton
Letvin, Norman L.
Walker, Bruce D.
Hahn, Beatrice H.
Korber, Bette T.
[J]. NATURE MEDICINE, 2007, 13 (01) : 100 - 106
[8] The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
Goonetilleke, Nilu
Liu, Michael K. P.
Salazar-Gonzalez, Jesus F.
Ferrari, Guido
Giorgi, Elena
Ganusov, Vitaly V.
Keele, Brandon F.
Learn, Gerald H.
Turnbull, Emma L.
Salazar, Maria G.
Weinhold, Kent J.
Moore, Stephen
Letvin, Norman
Haynes, Barton F.
Cohen, Myron S.
Hraber, Peter
Bhattacharya, Tanmoy
Borrow, Persephone
Perelson, Alan S.
Hahn, Beatrice H.
Shaw, George M.
Korber, Bette T.
McMichael, Andrew J.
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (06) : 1253 - 1272
[9] CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
Kiepiela, Photini
Ngumbela, Kholiswa
Thobakgale, Christina
Ramduth, Dhanwanthie
Honeyborne, Isobella
Moodley, Eshia
Reddy, Shabashini
de Pierres, Chantal
Mncube, Zenele
Mkhwanazi, Nompumelelo
Bishop, Karen
van der Stok, Mary
Nair, Kriebashnie
Khan, Nasreen
Crawford, Hayley
Payne, Rebecca
Leslie, Alasdair
Prado, Julia
Prendergast, Andrew
Frater, John
McCarthy, Noel
Brander, Christian
Learn, Gerald H.
Nickle, David
Rousseau, Christine
Coovadia, Hoosen
Mullins, James I.
Heckerman, David
Walker, Bruce D.
Goulder, Philip
[J]. NATURE MEDICINE, 2007, 13 (01) : 46 - 53
[10] Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination
Kong, Wing-Pui
Wu, Lan
Wallstrom, Timothy C.
Fischer, Will
Yang, Zhi-Yong
Ko, Sung-Youl
Letvin, Norman L.
Haynes, Barton F.
Hahn, Beatrice H.
Korber, Bette
Nabel, Gary J.
[J]. JOURNAL OF VIROLOGY, 2009, 83 (05) : 2201 - 2215

← 1 2 →